BTIG reiterates Buy rating on Verastem, $18 price target
BTIG reiterated its Buy rating on Verastem and maintained a price target of $18.00, suggesting a potential upside of 133.8% from the previous closing price.
BTIG reiterated its Buy rating on Verastem and maintained a price target of $18.00, suggesting a potential upside of 133.8% from the previous closing price.